POMALIDOMIDE: A NOVEL PROMISING IMMUNOMODULATORY AGENT IN THE TREATMENT OF REFRACTORY AND RELAPSED MULTIPLE MYELOMA
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 3
Abstract
Revival of thalidomide in the treatment of multiple myeloma (MM) has paved a path to search for compounds with increased antiangiogenic and anti-tumor effects, but decreased side-effects resulting in the development of thalidomide analogues .After lenalidomide, recently pomalidomide (3 amino thalidomide) has come up as a potential immunomodulatory drug (IMiD) which is found to be effective in relapsing and refractory MM. This novel agent has recently been approved by USFDA on 8th February, 2013. Pomalidomide differs from existing immunomodulatory agents in being extremely potent and safe in comparison. Lack of cross resistance with the existing agents offers advantage for its use in MM not responding to thalidomide, lenalidomide and bortezomib. Manageable myelosuppression is the only demonstrable effect observed. This review elucidates the available evidence on efficacy and safety of this drug in refractory and relapsing MM after analyzing various studies of this drug. Searches of pubmed, Cochrane database, Medscape, Google and clinicaltrial.org were made for terms like pomalidomide, multiple myeloma, immunomodulatory drugs.
Authors and Affiliations
Ruchika Nandha*| Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh , India, Kavita Sekhri| Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh , India, Harpal Singh| Consultant, Department of Critical Care, Max Superspeciality hospital, Phase 6, Mohali, India
Keywords
Related Articles
- EP ID EP1361
- DOI -
- Views 517
- Downloads 29
Planning social mobilization and communication for Dengue Hemorrhagic fever Diagnosis, Treatment, Prevention and Control: A step‑by‑step guide
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ~50 million dengue infections and ~500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly...
Hepatoprotective models and screening methods: a review
Liver, the largest organ in the body is being evolved to maintain the body’s internal milieu and also protect itself from the challenges it faces during its implementation. It is a essential organ having assorted functio...
DEVELOPMENT AND VALIDATION OF RP- HPLC SIMULTANEOUS ESTIMATION METHOD OF MONTELUKAST AND BAMBUTEROL FOR STABILITY INDICATING ASSAY
The objective of the current study was to develop and validate a simple, accurate, precise and selective stabilityindicating gradient reverse phase high performance liquid chromatographic method for simultaneous estimati...
COSHH AS LABORATORY SAFETY STANDARDS IN CONTROL OF SUBSTANCES HAZARDOUS TO HEALTH
COSHH is the law that requires employers to control substances that are hazardous to health. You can prevent or reduce workers exposure to hazardous substances by: finding out what the health hazards are, deciding how to...
Quercetin Nanocrystal Formulation: In Vitro Anti-tumor Activity against Dalton Lymphoma Cells
In this present work quercetin nanocrystal (QNC) has been formulated and investigated its anti-tumor activity against Dalton’s lymphoma cells (DLA) in an in vitro model. Since quercetin has poor water solubility, it has...